Koers NovAccess Global Inc. Other OTC
Aandelen
XSNX
US67001N1072
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 2,17 mln. 2 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -1 mln. -921K | Nettowinst (verlies) 2023 | -4 mln. -3,68 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 1,41 mln. 1,3 mln. | Nettoschuld 2023 | 2,36 mln. 2,17 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,16
x | K/w-verhouding 2023 |
-0,43
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 59,56% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 15-10-20 | |
Neil Laird
DFI | Director of Finance/CFO | 70 | 10-09-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 15-10-20 | |
Jason Anderson
BRD | Director/Board Member | 50 | 18-03-22 |
John Cassarini
CHM | Chairman | 57 | 14-03-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+44,48% | 54,04 mld. | |
+43,57% | 41,96 mld. | |
-0,86% | 41,92 mld. | |
-7,59% | 28,35 mld. | |
+12,30% | 26,35 mld. | |
-21,83% | 19 mld. | |
+7,15% | 13 mld. | |
+29,40% | 12,28 mld. | |
+25,15% | 12,19 mld. |